Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ is ready to roll out in the coming weeks. Poonawalla’s remarks came soon after the …
SIIs
-
- News
COVID-19 panel recommends SII’s Covishield for emergency use; new cases remain under 30,000 for 19th day – Health News , Firstpost
The daily new coronavirus infections in India remained below 30,000 for the 19th consecutive day on Friday, taking the total caseload to 1,02,86,709 The Subject Expert Committee (SEC) on COVID-19 …
- News
Centre may purchase 300-400 mn vaccine doses by July 2021, says SII’s Poonawalla after PM Modi’s visit
After Prime Minister Narendra Modi visited the company’s pandemic level facility in Pune, Serum Institute of India’s (SII), Chief Executive Officer (CEO) Adar Poonawalla on Saturday said that indications suggest …
- News
Chennai Volunteer for SII’s Covid Vaccine Claims Rs 5 Crore Compensation for Health Complications
A city-based 40-year-old business consultant, who was a volunteer for the Covishield vaccine that is under development at the Pune-based Serum Institute of India (SII), has sought Rs 5 crore …
- News
Chennai volunteer for SII’s COVID-19 vaccine claims Rs 5 crore compensation for health complications
A city-based 40-year-old business consultant, who was a volunteer for the Covidshield vaccine that is under development at the Pune-based Serum Institute of India (SII), has sought Rs 5 crore …